Dear colleagues,

these times are characterized by new (albeit not always) diagnostic and therapeutic methods for vascular diseases showing up almost every week. To assess any improvement thorough understanding of the underlying etiology and the interaction between blood flow and the atherosclerotic /aneuysmatic vessel is mandatory. This goal can only be achieved by mutual exchange between vascular clinicians and fundamental/translational researchers. Thereby, the 4th MAC aims to connect the frequently quite diverging worlds of fundamental science, clinical research and clinical practice.

Therefore we are very happy to invite you to the 4th edition of the Munich Aortic & Carotid Conference (MAC) on the first December weekend 2014. Again, the 4th MAC will focuse on aortic and carotid issues; a joint meeting with topics ranging from basic science and engineering to clinical issues and patient care. In detail, the aortic sessions will include aortic root and ascending aortic reconstructions, new treatment options for arch aneurysms, current indications for EVAR in acute aortic dissections and the management of type II endoleaks after EVAR. Further special sessions will address the current role of simulation techniques in modeling and understanding of vascular disease and prediction of treatment outcome. Since the technical progress in hybrid ORs is extremely rapid, we will again discuss options on how to optimize the workflow by using imaging fusion techniques and endovascular navigation.

The carotid sessions will feature topics, such as clinical trials, the optimal timing of invasive treatment in carotid-related cerebral ischemia, the interaction between asymptomatic carotid disease, MRI lesions and cognitive functions, carotid plaque vulnerability and training in CEA and CAS.

Many attendees of MAC favor to attend all main carotid and aortic sessions. To overcome the problem of parallel sessions, Friday, December 5th will be reserved for the main carotid sessions and Saturday, December 6th, for the main aortic sessions respectively. Parallel sessions will only be scheduled for special issues.

Again, we are very proud to present a world-class faculty of national and international experts in clinical and translational vascular research. Our speakers are very experienced presenters and all of them are keen to exchange their ideas with the audience. We are fully aware that in-depth discussion following the oral presentation is sometimes even more interesting for the audience than the lecture itself. Therefore, sufficient time is scheduled for extensive discussions with the audience.
The 4th MAC 2014 is a platform where clinical researchers from vascular / cardiovascular surgery, neurology, cardiology, angiology and anesthesiology can meet radiologists and imaging specialists, vascular
biologists and basic researchers in a very friendly and relaxed atmosphere.

Do not miss the opportunity to share the latest insights into the world of academic vascular research, represented by our world-class national and international faculty! The 4th MAC will provide you with late-breaking news and cutting-edge approaches in vascular medicine and will enable you to be part of the thrilling progress of improving the diagnosis and treatment of carotid and aortic diseases. The 4th MAC 2014 is being held under the patronage of the German Vascular Society (DGG) and the VASCULAR INTERNATIONAL foundation.

We look forward to welcoming you in Munich. 

Hans-Henning Eckstein
Rüdiger Lange
Markus Schwaiger
Holger Poppert
Alma Zernecke
Wolfgang Wall
Michael Gee